Atria Wealth Solutions’s West Pharmaceutical WST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$246K	Sell	1,123 -2,898	-72%	-$620K	0.01%	1261
2025 Q1	$900K	Buy	4,021 +1,258	+46%	+$347K	0.01%	930
2024 Q4	$905K	Sell	2,763 -205	-7%	-$64.5K	0.01%	964
2024 Q3	$891K	Sell	2,968 -318	-10%	-$97.4K	0.01%	951
2024 Q2	$1.08M	Sell	3,286 -309	-9%	-$109K	0.01%	864
2024 Q1	$1.42M	Sell	3,595 -88	-2%	-$32.6K	0.02%	754
2023 Q4	$1.3M	Sell	3,683 -29	-0.8%	-$10.3K	0.02%	761
2023 Q3	$1.39M	Sell	3,712 -163	-4%	-$63K	0.02%	686
2023 Q2	$1.48M	Sell	3,875 -116	-3%	-$41.4K	0.02%	684
2023 Q1	$1.38M	Sell	3,991 -149	-4%	-$43.5K	0.02%	686
2022 Q4	$974K	Sell	4,140 -401	-9%	-$95K	0.02%	762
2022 Q3	$1.12M	Buy	4,541 +568	+14%	+$173K	0.02%	682
2022 Q2	$1.2M	Sell	3,973 -2,985	-43%	-$971K	0.02%	627
2022 Q1	$2.86M	Buy	+6,958	New	+$2.72M	0.05%	386